Skip to main content
Enter the terms you wish to search for.
Select Search Option
This Site
All WCM Sites
Directory
Menu
Weill Cornell Medicine
Rockefeller
Sloan Kettering
Tri-Institutional MD-PhD Program
Explore this Website
Home
About Us
Toggle About Us menu options
Welcome from Dr. Katharine Hsu
Welcome from Tri-I Students
Leadership and Staff
Our Institutions
Contact Us
Getting to the Tri-Institutional Campus
Equal Education & Employment
Admissions
Toggle Admissions menu options
Transfer Policy
Admissions FAQs
Financial Support
Finance FAQs
Curriculum and Community
Toggle Curriculum and Community menu options
Program at a Glance
MD-PhD Specific Courses and Seminars
Tri-I Faculty
Our Students
Toggle Our Students menu options
Student Directory
Belonging at Tri-I
MD-PhD Houses
Student Housing
Life in New York City
Program FAQ
Tri-I Outcomes
Toggle Tri-I Outcomes menu options
Fellowships and Awards
Student Publications
Thesis Defenses
Residency Matches
Academic Career Progression
Career Paths of Our Alumni
Summer Program
Toggle Summer Program menu options
Gateways Admissions
Gateways To The Laboratory Summer Program FAQ
News and Events
Toggle News and Events menu options
Events Calendar
Weill Cornell Medicine
Care
Discover
Teach
Home
About Us
Admissions
Curriculum and Community
Tri-I Outcomes
Summer Program
News and Events
Home
Biblio
Found 4 results
Filters:
Keyword
is
Histocompatibility Antigens Class I
[Clear All Filters]
2024
Lee J, Oldham ML, Manon V, Chen J
. 2024.
Principles of peptide selection by the transporter associated with antigen processing.
.
Proc Natl Acad Sci U S A. 121(23):e2320879121.
2019
Boehm KMichael, Bhinder B, Raja VJoseph, Dephoure N, Elemento O
. 2019.
Predicting peptide presentation by major histocompatibility complex class I: an improved machine learning approach to the immunopeptidome.
.
BMC Bioinformatics. 20(1):7.
2018
Barkal AA, Weiskopf K, Kao KS, Gordon SR, Rosental B, Yiu YY, George BM, Markovic M, Ring NG, Tsai JM et al.
. 2018.
Engagement of MHC class I by the inhibitory receptor LILRB1 suppresses macrophages and is a target of cancer immunotherapy.
.
Nat Immunol. 19(1):76-84.
2016
Brea EJ, Oh CY, Manchado E, Budhu S, Gejman RS, Mo G, Mondello P, Han JE, Jarvis CA, Ulmert D et al.
. 2016.
Kinase Regulation of Human MHC Class I Molecule Expression on Cancer Cells.
.
Cancer Immunol Res. 4(11):936-947.